FDA AI Guidance Explained: What It Means for Medical Device Cybersecurity

How does the FDA’s latest AI guidance on medical devices impact manufacturers and cybersecurity challenges in healthcare?

In this episode, Christian and Trevor discuss the latest FDA AI guidance and how it will impact real-world AI applications in healthcare.

Key points:

• The FDA’s new guidance on AI in medical devices, released in January 2025.

• Differences between artificial intelligence (AI) and machine learning (ML).

• Historical context of AI, including early examples like Microsoft’s Clippy.

• Potential risks of AI in healthcare, including data poisoning, model inversion, and evasion.

• Challenges of ensuring AI integrity, confidentiality, and availability.

• The concept of model bias and how it impacts diagnostic accuracy.

• Practical cybersecurity strategies for AI-enabled medical devices.

• Importance of ongoing post-market monitoring to address performance drift.

• Value of consulting cybersecurity experts early in the development lifecycle.